FAS and FAS Ligand Polymorphisms in the Promoter Regions and Risk of Gastric Cancer in Southern China

Biochemical Genetics

Volumn 47, Issue 7-8, 2009, Pages 559-568

  Wang, Meilin ^a   Wu, Dongmei ^a   Tan, Ming ^b   Gong, Weida ^c   Xue, Hengchuan ^c   Shen, Hongbin ^a   Zhang, Zhengdong ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b Yangzhong Cancer Research Institute   (China)

^c YIXING PEOPLE S HOSPITAL   (China)

Author keywords

FAS; FAS ligand; Gastric cancer; Molecular epidemiology; Susceptibility

Indexed keywords

FAS ANTIGEN; FAS LIGAND;

ADULT; AGED; ARTICLE; CANCER RISK; CHINA; CHINESE; CONTROLLED STUDY; FAS GENE; FASLG GENE; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR EPIDEMIOLOGY; NUCLEOTIDE SEQUENCE; POPULATION BASED CASE CONTROL STUDY; PROMOTER REGION; STATISTICAL ANALYSIS; STOMACH CANCER; TRANSCRIPTION REGULATION;

AGED; ANTIGENS, CD95; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; FAS LIGAND PROTEIN; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; STOMACH NEOPLASMS;

EID: 67651229207     PISSN: 00062928     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10528-009-9264-0     Document Type: Article

References (36)

1. JY Chen CM Wang CC Ma YH Chow SF Luo 2005 The -844C/T polymorphism in the Fas ligand promoter associates with Taiwanese SLE Genes Immun 6 123 128
2. KD Crew AI Neugut 2004 Epidemiology of upper gastrointestinal malignancies Semin Oncol 31 450 464
3. GI Evan KH Vousden 2001 Proliferation, cell cycle and apoptosis in cancer Nature 411 342 348
4. QR Huang D Morris N Manolios 1997 Identification and characterization of polymorphisms in the promoter region of the human Apo-1/Fas (CD95) gene Mol Immunol 34 577 582
5. S Kanemitsu K Ihara A Saifddin T Otsuka T Takeuchi J Nagayama M Kuwano T Hara 2002 A functional polymorphism in fas (CD95/APO-1) gene promoter associated with systemic lupus erythematosus J Rheumatol 29 1183 1188
6. P Krippl U Langsenlehner W Renner H Koppel H Samonigg 2004 Re: polymorphisms of death pathway genes FAS and FASL in esophageal squamous-cell carcinoma J Natl Cancer Inst 96 1478 1479 (author reply 1479)
7. HC Lai HK Sytwu CA Sun MH Yu CP Yu HS Liu CC Chang TY Chu 2003 Single nucleotide polymorphism at Fas promoter is associated with cervical carcinogenesis Int J Cancer 103 221 225
8. SH Lee JY Lee WS Park SY Kim JJ Jang NJ Yoo 1999 Transitional cell carcinoma expresses high levels of Fas ligand in vivo BJU Int 83 698 702
9. SH Lee MS Shin WS Park SY Kim SM Dong JH Pi HK Lee HS Kim JJ Jang CS Kim SH Kim JY Lee NJ Yoo 1999 Alterations of Fas (APO-1/CD95) gene in transitional cell carcinomas of urinary bladder Cancer Res 59 3068 3072
10. C Li J Liu A Li L Qian X Wang Q Wei J Zhou Z Zhang 2005 Exon 3 polymorphisms and haplotypes of O6-methylguanine-DNA methyltransferase and risk of bladder cancer in southern China: a case-control analysis Cancer Lett 227 49 57
11. C Li D Larson Z Zhang Z Liu SS Strom JE Gershenwald VG Prieto JE Lee MI Ross PF Mansfield JN Cormier M Duvic EA Grimm Q Wei 2006 Polymorphisms of the FAS and FAS ligand genes associated with risk of cutaneous malignant melanoma Pharmacogenet Genomics 16 253 263
12. C Li W Wu J Liu L Qian A Li K Yang Q Wei J Zhou Z Zhang 2006 Functional polymorphisms in the promoter regions of the FAS and FAS ligand genes and risk of bladder cancer in south China: a case-control analysis Pharmacogenet Genomics 16 245 251
13. T Maeda Y Yamada R Moriuchi K Sugahara K Tsuruda T Joh S Atogami K Tsukasaki M Tomonaga S Kamihira 1999 Fas gene mutation in the progression of adult T cell leukemia J Exp Med 189 1063 1071
14. HH Nelson KT Kelsey MH Bronson LA Mott MR Karagas 2001 Fas/APO-1 promoter polymorphism is not associated with non-melanoma skin cancer Cancer Epidemiol Biomarkers Prev 10 809 810
15. S Ohno M Tachibana M Shibakita DK Dhar H Yoshimura S Kinugasa H Kubota R Masunaga N Nagasue 2000 Prognostic significance of Fas and Fas ligand system-associated apoptosis in gastric cancer Ann Surg Oncol 7 750 757
16. WS Park RR Oh YS Kim JY Park SH Lee MS Shin SY Kim PJ Kim HK Lee NY Yoo JY Lee 2001 Somatic mutations in the death domain of the Fas (Apo-1/CD95) gene in gastric cancer J Pathol 193 162 168
17. DM Parkin F Bray J Ferlay P Pisani 2005 Global cancer statistics, 2002 CA Cancer J Clin 55 74 108
18. ME Peter PH Krammer 1998 Mechanisms of CD95 (APO-1/Fas)-mediated apoptosis Curr Opin Immunol 10 545 551
19. H Shen A Solari X Wang Z Zhang Y Xu L Wang X Hu J Guo Q Wei 2004 P53 codon 72 polymorphism and risk of gastric cancer in a Chinese population Oncol Rep 11 1115 1120
20. K Sibley S Rollinson JM Allan AG Smith GR Law PL Roddam CF Skibola MT Smith GJ Morgan 2003 Functional FAS promoter polymorphisms are associated with increased risk of acute myeloid leukemia Cancer Res 63 4327 4330
21. M Stephens P Donnelly 2003 A comparison of bayesian methods for haplotype reconstruction from population genotype data Am J Hum Genet 73 1162 1169
22. M Stephens NJ Smith P Donnelly 2001 A new statistical method for haplotype reconstruction from population data Am J Hum Genet 68 978 989
23. T Suda T Takahashi P Golstein S Nagata 1993 Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family Cell 75 1169 1178
24. T Sun X Miao X Zhang W Tan P Xiong D Lin 2004 Polymorphisms of death pathway genes FAS and FASL in esophageal squamous-cell carcinoma J Natl Cancer Inst 96 1030 1036
25. T Sun Y Zhou H Li X Han Y Shi L Wang X Miao W Tan D Zhao X Zhang Y Guo D Lin 2005 FASL -844C polymorphism is associated with increased activation-induced T cell death and risk of cervical cancer J Exp Med 202 967 974
26. Y Takahama Y Yamada K Emoto H Fujimoto T Takayama M Ueno H Uchida S Hirao T Mizuno Y Nakajima 2002 The prognostic significance of overexpression of the decoy receptor for Fas ligand (DcR3) in patients with gastric carcinomas Gastric Cancer 5 61 68
27. CB Thompson 1995 Apoptosis in the pathogenesis and treatment of disease Science 267 1456 1462
28. CA Thomson K LeWinn TR Newton DS Alberts ME Martinez 2003 Nutrition and diet in the development of gastrointestinal cancer Curr Oncol Rep 5 192 202
29. J Wu C Metz X Xu R Abe AW Gibson JC Edberg J Cooke F Xie GS Cooper RP Kimberly 2003 A novel polymorphic CAAT/enhancer-binding protein beta element in the FasL gene promoter alters Fas ligand expression: a candidate background gene in African American systemic lupus erythematosus patients J Immunol 170 132 138
30. L Yang 2006 Incidence and mortality of gastric cancer in China World J Gastroenterol 12 17 20
31. C Zapata C Carollo S Rodriguez 2001 Sampling variance and distribution of the D'measure of overall gametic disequilibrium between multiallelic loci Ann Hum Genet 65 395 406
32. ZF Zhang RC Kurtz GP Yu M Sun N Gargon M Karpeh Jr JS Fein S Harlap 1997 Adenocarcinomas of the esophagus and gastric cardia: the role of diet Nutr Cancer 27 298 309
33. X Zhang X Miao T Sun W Tan S Qu P Xiong Y Zhou D Lin 2005 Functional polymorphisms in cell death pathway genes FAS and FASL contribute to risk of lung cancer J Med Genet 42 479 484
34. Z Zhang Y Xu J Zhou X Wang L Wang X Hu J Guo Q Wei H Shen 2005 Polymorphisms of thymidylate synthase in the 5'- and 3'-untranslated regions associated with risk of gastric cancer in South China: a case-control analysis Carcinogenesis 26 1764 1769
35. JH Zhao 2004 2LD, Genecounting, and HAP: computer programs for linkage disequilibrium analysis Bioinformatics 20 1325 1326
36. M Zornig A Hueber W Baum G Evan 2001 Apoptosis regulators and their role in tumorigenesis Biochim Biophys Acta 1551 F1 F37